C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/2011
08/25/2011	US20110206736 Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same
08/25/2011	US20110206730 Dengue Chimeric Viruses
08/25/2011	US20110206639 Replication competent viruses capable of silencing virus inhibitory factor expression
08/24/2011	EP2360257A2 Hepatitis B virus (HBV) variants
08/24/2011	EP2360243A1 Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
08/24/2011	EP2360174A1 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
08/24/2011	EP2359869A2 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same and uses therefor
08/24/2011	EP2359867A1 Method of increasing the function of an AAV vector
08/24/2011	EP2359866A1 Method of increasing the function of an AAV vector
08/24/2011	EP2359865A1 Method of increasing the function of an AAV vector
08/24/2011	EP1784487B1 Identification of cross-reactive epitopes of flavivirus envelope glycoprotein
08/24/2011	EP1545625B1 Flexible vaccine assembly and vaccine delivery platform
08/24/2011	EP1385540B1 Composition and method for increasing cell density in cell cultures infected with lentivirus
08/24/2011	EP1025121B1 Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
08/24/2011	CN102165062A New influenza virus immunizing epitope
08/24/2011	CN101864399B Enterovirus and application thereof
08/24/2011	CN101619306B Influenza B virus Vero cell productive adaptive strain and preparation and application thereof
08/23/2011	US8003364 Purification of vaccinia viruses using hydrophobic interaction chromatography
08/23/2011	US8003363 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
08/23/2011	US8003323 Reduction in bacterial colonization by administering bacteriophage compositions
08/23/2011	CA2469053C Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
08/23/2011	CA2324478C A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
08/23/2011	CA2283093C Recombinant chimeric viruses and uses thereof
08/23/2011	CA2238436C Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
08/18/2011	WO2011098837A1 Method for the production of stable live vaccine formulations
08/18/2011	WO2011098615A1 Cells modified for virus production by inhibition of the hipk2 gene
08/18/2011	WO2011098592A1 Method for the production of ad26 adenoviral vectors
08/18/2011	US20110201119 Alphavirus packaging cell lines
08/18/2011	US20110201088 Production of rAAV in Vero Cells Using Particular Adenovirus Helpers
08/18/2011	US20110201087 Compositions and Methods for the Production of Alpha-Herpesviruses
08/18/2011	US20110201086 Method for producing recombinant virus
08/18/2011	US20110201078 Ligand functionalized polymers
08/18/2011	US20110200630 Live attenuated virus vaccines for la crosse virus and other bunyaviridae
08/18/2011	US20110200561 Method for Bacteriophage Delivery and Amplification
08/18/2011	CA2786835A1 Method for the production of ad26 adenoviral vectors
08/17/2011	EP2357224A1 Method for isolating the dna of the avian infectious laryngotracheitis virus for pcr analysis
08/17/2011	EP2357010A1 Method of increasing the function of an AAV vector
08/17/2011	EP2355834A1 Anti-viral protection with viruses containing defective genome segments
08/17/2011	EP1731612B1 Recombinant herpesvirus and utilization of the same
08/17/2011	EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
08/17/2011	EP0939827B1 Lentiviral vectors
08/17/2011	CN102159705A Mutant pestivirus with mutations in core gene and ns3 region
08/17/2011	CN102154369A Recombinant slow virus vector, recombinant slow virus and stem cell containing recombinant slow virus
08/17/2011	CN102154367A Swine influenza virus H3N2 and H1N1 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
08/17/2011	CN102154366A Swine influenza virus H3N2 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
08/17/2011	CN102154365A Swine influenza virus H1N1 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
08/17/2011	CN102154356A Hybrid immunodeficiency plasmid containing human immunodeficiency virus (HIV)-1 circulating recombinant form (CRF) 01-AE subtype reverse transcriptase (RT) gene, virus and use
08/17/2011	CN102154325A Vaccine against human papillomavirus (HPV) as well as preparation method and application thereof
08/17/2011	CN102154306A Codon-optimized swine CD40L gene and preparation method for recombinant rhabdovirus for expressing protein coded by same
08/17/2011	CN102154229A EV71 virus-like particles and hand-foot-and-mouth disease vaccine prepared from EV71 virus-like particles
08/17/2011	CN102154228A Flow through purification processes for large biomolecules
08/17/2011	CN102154227A Chimeric virus of complete structural protein of hepatitis C virus and GB virus B
08/17/2011	CN102154226A Chimeric virus of complete envelope protein of HCV (hepatitis C virus) and GB virus B
08/17/2011	CN102154225A Recombinant adenovirus and construction method thereof
08/17/2011	CN102154224A Construction of recombinant chicken marek's disease vaccine virus SC9-1 strain and application thereof
08/17/2011	CN102154223A Recombinant adenovirus with fusion protein gene and preparation method and application thereof
08/17/2011	CN102154222A Vertical multi-layer closed nuclear polyhedrosis virus multiplication process
08/17/2011	CN102154221A Preparation of porcine circovirus II-type virus seed and storage method thereof
08/17/2011	CN102154220A Method and equipment for ultrahigh-density and large-scale production of porcine reproductive and respiratory syndrome virus (PRRSV)
08/17/2011	CN102154219A Swine influenza A H1N1 virus and use thereof
08/17/2011	CN102154213A Novel cytokine-induced killer (CIK) cells for carrying cytokine loaded double-regulated oncolytic adenovirus
08/17/2011	CN102153656A Vaccine for chimeric virus-like particles and preparation method thereof
08/17/2011	CN101845419B Recombinant adenovirus and application thereof
08/16/2011	US7998734 Expression vector comprising nucleotide sequences coding factor IX for treatment of blood disorders
08/16/2011	US7998488 Vaccine formulations and uses thereof
08/16/2011	US7998482 Methods and reagents for the analysis and purification of polysaccharides
08/11/2011	WO2011097447A2 Production of recombinant virus
08/11/2011	WO2011095760A1 Bunyavirus vaccine
08/11/2011	WO2011095596A1 Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
08/11/2011	WO2011054996A3 Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus
08/11/2011	WO2010115735A3 Methods for inactivating viruses
08/11/2011	US20110195088 Porcine Reproductive and Respiratory Syndrome Isolates and Methods of Use
08/11/2011	DE10121283B4 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen Methods and vectors for amplification or expression of the desired nucleic acid sequences in plants
08/11/2011	CA2788902A1 Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
08/10/2011	EP2354221A2 Porcine circovirus type 2 and use thereof
08/10/2011	EP1481084B1 The use of ribozymes in the detection of adventitious agents
08/10/2011	EP1135513B2 Adenovirus-mediated gene therapy
08/10/2011	CN1796546B Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin
08/10/2011	CN102149817A Production of infectious hepatitis c virus particles in cell culture
08/10/2011	CN102149816A Novel bacteriophage and antibacterial composition comprising same
08/10/2011	CN102146418A Recombinant II type herpes simplex virus vector, preparation method of recombinant II type herpes simplex virus vector, recombinant virus, medicinal composition and application
08/10/2011	CN102146130A Plant stress tolerance associated protein SeVP2 as well as coding gene and application thereof
08/10/2011	CN102146129A Protein SeVP1 related to stress tolerance of plants and encoding gene and application thereof
08/10/2011	CN102145165A Porcine circovirus type 2 and use thereof
08/10/2011	CN101748102B Method for production of porcine epidemic diarrhea virus
08/09/2011	US7993924 Using myxoviral vector as somatic gene therapeutic tool; genetic vaccines
08/09/2011	US7993651 Administering gag protein; vaccines for human immunodeficiency virus
08/09/2011	CA2409209C Chimeric arterivirus-like particles
08/09/2011	CA2302809C Membrane virus host range mutations and their uses as vaccine substrates
08/04/2011	WO2011094198A1 A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
08/04/2011	WO2011093692A1 Method for newcastle disease virus propagation in a bioreactor
08/04/2011	WO2011093180A1 Culture information-generating device, culture device and culture method
08/04/2011	WO2011092199A1 Mutated xmrv env proteins in the immunosuppressive domain
08/04/2011	WO2011092029A1 Vaccinia virus mutants containing the major genomic deletions of mva
08/04/2011	US20110190166 Erythroid progenitor cells and methods for producing parvovirus b19 therein
08/04/2011	US20110189652 Viral variants with altered susceptability to nucloeside analogs and uses thereof
08/04/2011	US20110189234 Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles
08/04/2011	US20110189233 Recombinant Varicella-Zoster Virus
08/04/2011	US20110189232 RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1
08/04/2011	US20110189227 Porcine circovirus type 2 and use thereof

1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 267